通气早产儿出生后7至14天启动全身氢化可的松治疗对2岁矫正年龄死亡与神经发育的影响:随机临床试验随访
Effect of Systemic Hydrocortisone Initiated 7 to 14 Days After Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years' Corrected Age: Follow-up of a Randomized Clinical Trial.
PubMed 文献 · JAMA · 2021-01-01
该研究为STOP-BPD随机临床试验的随访,评估通气依赖的极早产儿出生后7至14天启动全身氢化可的松治疗在2岁矫正年龄时死亡与神经发育损害的预设复合结局,原文摘要未报告具体结果。
要点
- 随访评估通气极早产儿氢化可的松治疗后的远期神经发育结局
- 主要结局为2岁矫正年龄死亡与神经发育损害的复合指标
- 原文摘要未提供具体效应数值,需查阅全文获取结果
研究设计与样本
- STOP-BPD随机临床试验的随访研究,对象为荷兰和比利时胎龄36周时仍依赖通气的极早产儿。
- 评估出生后7至14天启动全身氢化可的松治疗对2岁矫正年龄死亡与神经发育损害的预设复合结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This follow-up to the STOP-BPD randomized clinical trial, which investigated the efficacy and safety of systemic hydrocortisone treatment initiated 7 to 14 days after birth in ventilator-dependent, very preterm infants in the Netherlands and Belgium at 36 weeks’ postmenstrual age, examines the prespecified composite of death and neurodevelopmental impairment among these infants at 2 years’ corrected age.
来源:JAMA,查看原文。版权归原作者所有。
引用
- Halbmeijer NM, Onland W, Cools F, et al. Effect of Systemic Hydrocortisone Initiated 7 to 14 Days After Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years' Corrected Age: Follow-up of a Randomized Clinical Trial. JAMA. 2021. PMID: 34313697. doi:10.1001/jama.2021.9380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。